Predictive validity of the GOSLON Yardstick index in patients with unilateral cleft lip and palate: A systematic

Cindy Buj-Acosta1, Vanessa Paredes-Gallardo1, José María Montiel-Company2

  • 1Orthodontics Teaching Unit, Department of Dental Medicine, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain.

Plos One
|June 2, 2017
PubMed

Insights

The GOSLON Yardstick index, used for unilateral cleft lip and palate (UCLP) treatment, shows limited predictive validity for jaw growth. Further research is needed to validate its effectiveness in children with UCLP.

Area of Science:

  • Craniofacial surgery
  • Pediatric dentistry
  • Orthodontics

Background:

  • The GOSLON Yardstick is widely used to assess treatment outcomes in unilateral cleft lip and palate (UCLP) patients.
  • Outcomes in UCLP are closely related to jaw growth, making accurate measurement crucial.

Purpose of the Study:

  • To systematically review and validate the predictive accuracy of the GOSLON Yardstick for jaw growth in UCLP patients.
  • To assess the current evidence supporting the GOSLON Yardstick's predictability in UCLP treatment outcomes.

Main Methods:

  • A systematic literature review was performed across Medline, Cochrane Library, Scopus, and Embase databases.
  • Manual searches and grey literature searches were conducted to identify all relevant studies.
  • Inclusion criteria were applied to filter 131 initially identified articles down to three relevant studies.

Main Results:

  • The predictive validity of the GOSLON Yardstick ranged from 42.2% to 64.7% in the reviewed studies.
  • This indicates a moderate to low level of accuracy in predicting jaw growth outcomes.
  • A significant lack of robust evidence was found regarding the index's predictive capabilities.

Conclusions:

  • The current evidence suggests the GOSLON Yardstick has limited predictive validity for jaw growth in UCLP patients.
  • There is a need for more high-quality research to establish reliable growth prediction methods for UCLP.
  • The findings highlight potential limitations in using the GOSLON Yardstick for treatment efficacy assessment in this population.